Breaking News
Start for Free 0
🥇 First rule of investing? Know when to save! Up to 55% off Investing Pro before BLACK FRIDAY
CLAIM SALE
Close

Kilitch Drugs India Ltd (KIDI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
304.50 -6.65    -2.14%
08/11 - Closed. Currency in INR
Type:  Equity
Market:  India
ISIN:  INE729D01010 
S/N:  KILITCH
  • Volume: 11,444
  • Bid/Ask: 303.90 / 304.50
  • Day's Range: 301.00 - 314.00
Kilitch Drugs India Ltd 304.50 -6.65 -2.14%

NS:KIDI Financials

 
Gain a comprehensive overview of Kilitch Drugs India Ltd financials. Assess key figures from the balance sheet and income statement. Explore essential metrics such as total assets, total liabilities, equity, revenue, and net income to understand the company’s overall financial performance.

Kilitch Drugs (India) Limited reported earnings results for the first quarter ended June 30, 2024. For the first quarter, the company reported sales was INR 334.52 million compared to INR 365.57 million a year ago. Revenue was INR 360.25 million compared to INR 371.2 million a year ago. Net income was INR 13.4 million compared to INR 33.57 million a year ago. Basic earnings per share from continuing operations was INR 0.83 compared to INR 2.15 a year ago. Diluted earnings per share from continuing operations was INR 0.83 compared to INR 2.15 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

KIDI Income Statement

Gross margin TTM 46.79%
Operating margin TTM 10.73%
Net Profit margin TTM 8.32%
Return on Investment TTM 5.63%
 Total Revenue  Net Income
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Total Revenue 334.52 448.19 317.94 412.02
Gross Profit 149.2 200.62 148.06 209.97
Operating Income 8.08 61.48 14.65 78.03
Net Income 13.4 35.94 29.09 47.41

KIDI Balance Sheet

Quick Ratio MRQ 2.06
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 17.95%
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Total Assets 2400.62 2370.05
Total Liabilities 643.88 703.29
Total Equity 1756.73 1756.73 1666.76 1666.76

KIDI Cash Flow Statement

Cash Flow/Share TTM -0.09
Revenue/Share TTM 94.06
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

KIDI Comments

Write your thoughts about Kilitch Drugs India Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
ANIRUDH SHARMA
ANIRUDH Dec 29, 2021 16:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy now at current price
Vijay Pepavanshi
Vijay Pepavanshi May 03, 2021 19:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy
Nifty View
Nifty View Jan 23, 2019 11:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SELL SELL ........KILITCH DRUGS..... SELL SELL @_8_9_8_2_5_5_3_6_8_9_
sai krishnan
sai krishnan Jan 16, 2019 10:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy for intraday tgt 228
Vijay Maurya
Vijay Maurya Jan 04, 2019 14:13
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very good stock
Arvind Bera
Arvind Bera Nov 22, 2018 12:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Expext huge profit in this stock buy and hold and wait for multiple return
dilip choudhary
dilip choudhary Nov 16, 2018 20:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
kilitch is very good company and its profit in next quarter will be very good as it's fundamentals is strong and promotor holding is also increases in this quarter
dilip choudhary
dilip choudhary Nov 16, 2018 20:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
kilitch is very good company and its profit in next quarter will be very good as it's fundamentals is strong and promotor holding is also increases in this quarter
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email